-
Mashup Score: 0
Coronavirus disease 2019 (COVID-19) revived interest in convalescent plasma (CP) as a therapeutic option against novel pathogens. CP therapy involves the administration of antibodies against a pathogen [e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] to prevent or treat an infectious disease, and has been used periodically for more than a century. Historical experiences…
Source: Trends in Molecular MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0A call for disability health curricula in medical schools - 2 year(s) ago
People with disabilities encounter significant health and health-care inequities yet disability health training in medical education remains inadequate. This Scientific Life article examines the need to integrate disability health education into medical school curricula and shares successful training examples that can serve as a framework for how to accomplish this.
Source: Trends in Molecular MedicineCategories: General Medicine News, Latest HeadlinesTweet-
"A call for disability health curricula in medical schools" @deafmd1 Read more in @TrendsMolecMed https://t.co/YD30mfaY59
-
-
Mashup Score: 0A call for disability health curricula in medical schools - 2 year(s) ago
People with disabilities encounter significant health and health-care inequities yet disability health training in medical education remains inadequate. This Scientific Life article examines the need to integrate disability health education into medical school curricula and shares successful training examples that can serve as a framework for how to accomplish this.
Source: Trends in Molecular MedicineCategories: General Medicine News, Latest HeadlinesTweet-
"A call for disability health curricula in medical schools" @deafmd1 Read more in @TrendsMolecMed https://t.co/YD30mfbvUH
-
-
Mashup Score: 1A call for disability health curricula in medical schools - 2 year(s) ago
People with disabilities encounter significant health and health-care inequities yet disability health training in medical education remains inadequate. This Scientific Life article examines the need to integrate disability health education into medical school curricula and shares successful training examples that can serve as a framework for how to accomplish this.
Source: Trends in Molecular MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @DRaja_DNP: A call for #DisabilityHealthCurricula in #MedicalSchools Sanjana Ratakonda, et al. @UMich https://t.co/TE59mUAILl @CellPress…
-
-
Mashup Score: 2
Coronavirus disease 2019 (COVID-19) revived interest in convalescent plasma (CP) as a therapeutic option against novel pathogens. CP therapy involves the administration of antibodies against a pathogen [e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] to prevent or treat an infectious disease, and has been used periodically for more than a century. Historical experiences…
Source: Trends in Molecular MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Convalescent plasma to deliver therapeutic antibodies against COVID-19 [Feb 21, 2022] @jwsenefeld @ACasadevall1 @DrMJoyner @TrendsMolecMed https://t.co/lGbYqH09iD #COVID19CP #COVID19 https://t.co/f3NQtD8ga3
-
-
Mashup Score: 3Cutaneous neuroimmune crosstalk in pruritus - 2 year(s) ago
The underlying mechanisms of chronic pruritus (CP), which is often very debilitating for patients, are still not well understood. Over the past few years, peripheral and central mechanisms involving different classes of pruriceptive and nociceptive neuron (e.g., C- and Aδ-fibers), immune cells (e.g., eosinophils, basophils, Th1, Th2, and mast cells) and epithelial cells (e.g., keratinocytes) have…
Source: Trends in Molecular MedicineCategories: General Medicine News, Latest HeadlinesTweet-
Out now! Cutaneous neuroimmune crosstalk in pruritus - read the full review by Sonja Ständer @WWU_Muenster in @TrendsMolecMed #AAI2022 https://t.co/rsvwOCqr3o
-
-
Mashup Score: 5Primary B cell engineering for therapeutic research - 2 year(s) ago
Peripheral blood mononuclear cells (PBMCs) are harvested from patients and purified for CD19+ B cells. B cells can also be derived from iPSCs. Purified B cells are activated/expanded in culture to prime them for genome engineering. Lentivirus, transposons, and CRISPR/Cas9 together with recombinant adeno-associated viral vector (rAAV) carrying DNA donor template for homology directed repair (HDR)…
Source: Trends in Molecular MedicineCategories: General Medicine News, Latest HeadlinesTweet-
Check out this strategy of the month: Primary B cell engineering for therapeutic research, by Branden S. Moriarity @mw_umn_labs & others@TrendsMolecMed #AAI2022 https://t.co/7yumAMbJHr
-
-
Mashup Score: 9Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection - 2 year(s) ago
Humoral alloimmunity of organ transplant recipient to donor can lead to antibody-mediated rejection (ABMR), causing thousands of organ transplants to fail each year worldwide. However, the mechanisms of adaptive immune cell responses at the basis of humoral alloimmunity have not been entirely understood. In this review, we discuss how recent investigations have uncovered the key contributions of…
Source: Trends in Molecular MedicineCategories: General Medicine News, Latest HeadlinesTweet-
New review from Diana Metes's lab & others: Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection @InstituteStarzl @TrendsMolecMed #AAI2022 https://t.co/frmQ7a5iBS
-
-
Mashup Score: 10
The coronavirus disease 2019 (COVID-19) pandemic will change how we communicate biomedical science to reflect the new realities of increasing politicization of vaccines or therapeutics, as well as targeted attacks against prominent US scientists. The stakes are high, given how thousands of Americans are losing their lives by refusing vaccinations or demanding unproven treatments.
Source: Trends in Molecular MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
Communicating science and protecting scientists in a time of political instability: My latest @TrendsMolecMed https://t.co/Tx7fCWVYzw
-
-
Mashup Score: 4
Coronavirus disease 2019 (COVID-19) revived interest in convalescent plasma (CP) as a therapeutic option against novel pathogens. CP therapy involves the administration of antibodies against a pathogen [e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] to prevent or treat an infectious disease, and has been used periodically for more than a century. Historical experiences…
Source: Trends in Molecular MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Convalescent plasma to deliver therapeutic antibodies against COVID-19 [Feb 21, 2022] @jwsenefeld @ACasadevall1 @DrMJoyner @TrendsMolecMed https://t.co/lGbYqH09iD #COVID19CP #COVID19
-
Convalescent plasma to deliver therapeutic antibodies against COVID-19 [Feb 21, 2022] @jwsenefeld @ACasadevall1 @DrMJoyner @TrendsMolecMed https://t.co/lGbYqGIxU3 #COVID19CP #COVID19 https://t.co/4FqETCqlj2